Bicycle Therapeutics (BCYC) Net Equity Issued and Repurchased (2021 - 2024)
Bicycle Therapeutics (BCYC) posted Net Equity Issued and Repurchased of -$979000.0 for Q3 2024, down 9890.0% on a QoQ basis from $10000.0 in Q4 2023, and down 105.05% year-over-year from $19.4 million in Q4 2023.
Bicycle Therapeutics (BCYC) Net Equity Issued and Repurchased (2021 - 2024) Analysis & Trends
Bicycle Therapeutics' Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at -$979000.0 for Q3 2024.
- Quarterly Net Equity Issued and Repurchased fell 105.05% year-over-year to -$979000.0 in Q3 2024, while the trailing twelve-month figure through Dec 2024 was $18.4 million (down 46.15% YoY) and the FY2024 annual result came in at $544.1 million, up 118.22% from the prior year.
- Net Equity Issued and Repurchased was -$979000.0 for Q3 2024 at Bicycle Therapeutics, down from $10000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $188.4 million in Q4 2021 and bottomed at -$979000.0 in Q3 2024.
- A 3-year average of $35.9 million and a median of $12.1 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
- Peak annual rise in Net Equity Issued and Repurchased reached 105.05% in 2024, while the deepest fall reached 105.05% in 2024.
- Bicycle Therapeutics' Net Equity Issued and Repurchased stood at $188.4 million in 2021, then slumped by 99.99% to $10000.0 in 2023, then slumped by 9890.0% to -$979000.0 in 2024.
- Business Quant data shows BCYC's Net Equity Issued and Repurchased at -$979000.0 in Q3 2024, $10000.0 in Q4 2023, and $19.4 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -979,000.00 |
| Sep 30, 2024 | -979,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Sep 30, 2023 | 19.40 Mn |
| Sep 30, 2023 | 19.40 Mn |
| Jun 30, 2023 | 12.10 Mn |
| Jun 30, 2023 | 12.10 Mn |
| Mar 31, 2023 | 2.72 Mn |
| Mar 31, 2023 | 2.72 Mn |
| Dec 31, 2021 | 188.39 Mn |
| Dec 31, 2021 | 188.39 Mn |
| Sep 30, 2021 | 29.84 Mn |
| Sep 30, 2021 | 29.84 Mn |